Pertuzumab ELISA Kit

SKU:BHE21400356
Overview
Click light‑blue chips for details
Pertuzumab ELISA Kit is a quantitative colorimetric ELISA for measuring Pertuzumab levels in plasma, serum. The assay covers a 0.31-5 μg/mL standard-curve range, detects down to 0.156 μg/mL, with typical spike recovery of 80-120%, supporting reproducible standard-curve quantification across experimental conditions.
Assay Type Quantitative Colorimetric ELISA
Sample Type Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Plate Format 96-well (96T)
Options selector
Catalog no. Size
DY286028-96T 96 T
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 96 T
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
  • Shipping: 2-8 °C
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Target Pertuzumab
Alternative names OMNITARG, rhuMAB 2C4
UniProt # P04626
CAS no. 380610-27-5
Reactivity
  • Human
Applications
  • ELISA
Assay type
  • Quantitative
Sample type(s) Plasma, Serum
Sensitivity 0.156 μg/mL
Detection range 0.31-5 μg/mL
Detection method
  • Colorimetric
Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 ℃
Catalog no. (Mfr.) DY286028
Main SKU BHE21400356
Therapeutic Drug Monitoring

Assay Principle

Pertuzumab ELISA Kit provides plate-based quantitative measurement of Pertuzumab. Each run carries its own standard series, so results remain comparable across plates, days, and operators in a research workflow.

Background

Pertuzumab (also called 2C4, trade name Perjeta) is a humanized (from mouse) monoclonal antibody (mAb) used in combination with trastuzumab and docetaxel for the treatment of metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer. It was discovered and developed by Genentech, a subsidiary of Roche, and was first approved in 2012. It is manufactured recombinantly in Chinese hamster ovary (CHO) cells. The monoclonal antibody 2C4 appears to have first been published in 1990 by scientists from Genentech. By 2003 Genentech understood that 2C4 prevented HER2 dimerizing with other HER receptors and had begun Phase I trials, aiming for a broad range of cancers, not just one’s overexpressing HER2. It was the first known HER dimerization inhibitor. In 2005 Genentech presented poor results of Phase II trials of pertuzumab as a single agent in prostate, breast, and ovarian cancers, and said that it intended to continue developing it in combination with other drugs for ovarian cancer. In 2007 Genentech dropped the trade name Omnitarg. In 2012 the results were published of the CLEOPATRA trial, a randomized placebo-controlled Phase III trial of pertuzumab in combination with trastuzumab and docetaxel in HER2-positive metastatic breast cancer. Pertuzumab received US Food and Drug Administration (FDA) approval for the treatment of HER2-positive metastatic breast cancer later that year. The FDA approved the neoadjuvant indication in 2013. Pertuzumab was approved in Europe in 2013.

Specifications

Assay Type Quantitative Colorimetric ELISA
Detection Method Colorimetric
Plate Format 96-well (96T)
Sample Types Plasma, Serum
Sensitivity 0.156 μg/mL
Detection Range 0.31-5 μg/mL
Recovery 80-120%
Stability & Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping 2-8 °C
CAS Number 380610-27-5
UniProt P04626
Alternative Names OMNITARG, rhuMAB 2C4

Performance Data

The kit provides a quantitative range of 0.31-5 μg/mL, an analytical sensitivity of 0.156 μg/mL, typical spike recovery of 80-120%. Plan sample dilutions so readouts fall within the linear portion of the standard curve, and evaluate matrix effects with dilution-linearity and spike-recovery controls.

Target Notes

The target is also referenced in the literature as OMNITARG, rhuMAB 2C4. Curated target information is available under UniProt accession P04626. The corresponding compound is registered under CAS 380610-27-5.

Common Research Applications

  • Pharmacokinetic profiling of the drug in preclinical and translational research models
  • Bioanalytical method development, bridging, and comparability studies
  • Stability and formulation studies requiring reproducible concentration readouts

Safety & Handling

For Research Use Only. Not for diagnostic or therapeutic use. Handle all reagents and samples according to your institution's laboratory safety guidelines, and store components as recommended to preserve assay performance.

Q.Which sample types are compatible with this kit?
A.The kit is validated for Plasma, Serum. For other matrices, evaluate dilution linearity and spike recovery before routine use.
Q.What is the detection limit?
A.The analytical sensitivity is 0.156 μg/mL. Samples near the detection limit should be run with replicates for reliable interpretation.
Q.What is the quantitative range?
A.The standard curve covers 0.31-5 μg/mL. Dilute concentrated samples so readings fall within this range.
Q.How should the kit be stored?
A.The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Q.How is the kit shipped?
A.The kit ships at 2-8 °C. Refrigerate upon receipt and follow the datasheet for component-level storage.
Q.Is this kit for diagnostic use?
A.No. This product is For Research Use Only (RUO) and is not intended for diagnostic or therapeutic procedures.

Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today